Drug intelligence / Profile preview

helium + hyperpolarized xenon-129 + nitrogen

Development stage
Unknown
Lead developer
Polarean Imaging
Modality
Small Molecules
Administration
Inhalation
01

Overview

**helium + hyperpolarized xenon-129 + nitrogen** is a gas-based MRI contrast agent formulation used to generate inhaled hyperpolarized xenon-129 for pulmonary ventilation imaging. In the provided context, it refers specifically to the isotopically enriched xenon Xe 129 source gas blend used with Polarean's HPX Hyperpolarization System, consisting of helium, nitrogen, and a small fraction of xenon enriched for Xe-129; after hyperpolarization and preparation, the resulting inhaled agent is used as an MRI-visible contrast medium that distributes through ventilated lung regions rather than acting through a conventional pharmacologic receptor target. This formulation is associated with Polarean's XENOVIEW program for evaluation of lung ventilation, including use in disorders such as COPD, idiopathic pulmonary fibrosis, asthma, cystic fibrosis, and perioperative lung assessment.

Other names
helium + hyperpolarized xenon-129 + nitrogenisotopically enriched xenon Xe 129 gas blendhyperpolarized xenon Xe 129 gas blend

Beyond the preview

Go deeper on helium + hyperpolarized xenon-129 + nitrogen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on helium + hyperpolarized xenon-129 + nitrogen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call